AdvisorShares Pure US Cannabis ETF MSOS
4.33 USD -0.16 (-3.56%)
At closeNov 4, 2026, 5:38 PM EST
4.33 0.00 0.00%
After hours · Nov 4, 5:38 PM ET
4.25 Day range 4.79
2.96 52-week range 7.25
- YTD
- -8.26%
- 1 year
- +3.59%
- Market cap
- 583.15M
- YTD return
- -8.26%
- 1-year return
- +3.59%
- Volume
- 12.69M
- Avg volume
- 4.90M
- Open
- 4.73
- Previous close
- 4.49
- Day's range
- 4.25 – 4.79
- 52-week range
- 2.96 – 7.25
5D +0.27 (+6.67%)
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 5.35
- 200-day average
- 7.29
About AdvisorShares Pure US Cannabis ETF
The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from the marijuana and hemp business in the United States and in derivatives that have economic characteristics similar to such securities. It will concentrate at least 25% of its investments in the pharmaceuticals, biotechnology & life sciences industry group within the health care sector. The fund is non-diversified.
News
Curaleaf's Higher Aurora Bid Raises the Stakes in Cannabis Consolidation 
AdvisorShares Pure US Cannabis ETF (NYSEARCA:MSOS) Shares Gap Down – Here’s What Happened 
MSOS: Pause On Cannabis Rescheduling - And Why Trulieve Is A Sneaky Pick 
'DEA Judge Pauses Marijuana Rescheduling Hearing As Opponents Highlight Government Report Detailing ‘Gaps’ In Federal Processes'- Marijuana Moment 
Tilray Jumps 6%, Canopy Growth Climbs 3%, Aurora Cannabis Gains 4%: Here's Why TLRY Is Still Down 47% YTD 
Virginia and Texas Are About to Become Cannabis Battlegrounds. Here's Which Stocks Are Positioned to Win. 
MSOS: Adult-Use Rescheduling The Next Catalyst For Cannabis Stocks 
The Easiest Way to Bet on US Cannabis Is This One ETF 
Trulieve Makes History As First US Cannabis Stock On NYSE 
'White House Pushes Congress To Keep Hemp CBD Products Legal By Amending Broad Ban That's Set To Take Effect Later This Year' - Marijuana Moment
Your note
Sign in to keep a note on MSOS — it syncs with the Stock Master app.